NCT00024284View on ClinicalTrials.gov

Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

carboplatin

DRUG

irinotecan hydrochloride

Trial Locations (7)

10021

Memorial Sloan-Kettering Cancer Center, New York

15213

Children's Hospital of Pittsburgh, Pittsburgh

63105

Washington University Medical Center, St Louis

85724

Arizona Cancer Center, Tucson

20010-2916

Children's National Medical Center, Washington D.C.

38105-2794

St. Jude Children's Research Hospital, Memphis

M5G 1X8

Hospital for Sick Children, Toronto

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Bristol-Myers Squibb

INDUSTRY

NCT00024284 - Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter